Lenalidomide hydrochloride
Lenalidomide hydrochloride
 Lenalidomide hydrochloride |
|
A3547-250 |
ApexBio |
250 mg |
EUR 224 |
|
Description: IC50 Value: 13 nM [1] Lenalidomideis a derivative of thalidomide introduced in 2004. Lenalidomide (Revlimid, CC-5013) is a TNF-? secretion inhibitor with IC50 of 13 nM. in vitro: Lenalidomide strongly induces IL-2 and sIL-2R production. |
Lenalidomide hydrochloride |
|
A3547-50 |
ApexBio |
50 mg |
EUR 154 |
|
Description: IC50 Value: 13 nM [1] Lenalidomideis a derivative of thalidomide introduced in 2004. Lenalidomide (Revlimid, CC-5013) is a TNF-? secretion inhibitor with IC50 of 13 nM. in vitro: Lenalidomide strongly induces IL-2 and sIL-2R production. |
Lenalidomide hydrochloride |
|
A3547-500 |
ApexBio |
500 mg |
EUR 258 |
|
Description: IC50 Value: 13 nM [1] Lenalidomideis a derivative of thalidomide introduced in 2004. Lenalidomide (Revlimid, CC-5013) is a TNF-? secretion inhibitor with IC50 of 13 nM. in vitro: Lenalidomide strongly induces IL-2 and sIL-2R production. |
) Lenalidomide-C4-NH2 (hydrochloride) |
|
HY-115446A |
MedChemExpress |
500mg |
EUR 1714 |
 Lenalidomide |
|
20-abx076543 |
Abbexa |
|
|
- Shipped within 5-12 working days.
|
Lenalidomide |
|
L044-100MG |
TOKU-E |
100 mg |
EUR 178 |
Lenalidomide |
|
L044-25MG |
TOKU-E |
25 mg |
EUR 78 |
 Lenalidomide hemihydrate |
|
B1188-100 |
ApexBio |
100 mg |
EUR 122 |
|
Description: Lenalidomide (Revlimid, CC-5013) is a TNF-? secretion inhibitor with IC50 of 13 nM. |
) Lenalidomide (CC-5013) |
|
A4211-100 |
ApexBio |
100 mg |
EUR 189 |
|
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
|
A4211-250 |
ApexBio |
250 mg |
EUR 224 |
|
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
|
A4211-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 113 |
|
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
|
A4211-50 |
ApexBio |
50 mg |
EUR 154 |
|
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
|
A4211-500 |
ApexBio |
500 mg |
EUR 258 |
|
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
|
A4211-S |
ApexBio |
Evaluation Sample |
EUR 81 |
|
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
-Lenalidomide) (R,S)-Lenalidomide |
|
1862-100 |
Biovision |
|
EUR 245 |
-Lenalidomide) EZSolution? (R,S)-Lenalidomide |
|
B1503-10 |
Biovision |
|
EUR 120 |
) Lenalidomide (Ubiquitin ligase inducer) |
|
SIH-410-10MG |
Stressmarq |
10 mg |
EUR 149 |
- Clinically, lenalidomide has proven to be effective in the treatment of multiple myeloma and other B cell diseases. It has the ability to selectively bind and ubiquitinate two lymphoid transcription factors, IKZF1 and IKZF2, via the CRBN-CRL4 ubiquit
- Show more
|
|
Description: The substance Lenalidomide is a ubiquitin ligase inducer. It is synthetically produced and has a purity of >98%. The pure substance is powder which is soluble in DMSO (200 mM), Water (<1 mM) and Ethanol (<1 mM).. |
Lenalidomide (Ubiquitin ligase inducer) |
|
SIH-410-50MG |
Stressmarq |
50 mg |
EUR 317 |
- Clinically, lenalidomide has proven to be effective in the treatment of multiple myeloma and other B cell diseases. It has the ability to selectively bind and ubiquitinate two lymphoid transcription factors, IKZF1 and IKZF2, via the CRBN-CRL4 ubiquit
- Show more
|
|
Description: The substance Lenalidomide is a ubiquitin ligase inducer. It is synthetically produced and has a purity of >98%. The pure substance is powder which is soluble in DMSO (200 mM), Water (<1 mM) and Ethanol (<1 mM).. |
) Stachydrine (hydrochloride) |
|
C3648-100 |
ApexBio |
100 mg |
EUR 119 |
|
Description: Stachydrine is an anti-metastatic agent.Stachydrine, a pyrrolidine betaine, was first isolated from seed husk and the pulp of the fruit of C. Leonurus, and many other Asian plants and fruits. |
Stachydrine (hydrochloride) |
|
C3648-1000 |
ApexBio |
1 g |
EUR 467 |
|
Description: Stachydrine is an anti-metastatic agent.Stachydrine, a pyrrolidine betaine, was first isolated from seed husk and the pulp of the fruit of C. Leonurus, and many other Asian plants and fruits. |
Stachydrine (hydrochloride) |
|
C3648-250 |
ApexBio |
250 mg |
EUR 206 |
|
Description: Stachydrine is an anti-metastatic agent.Stachydrine, a pyrrolidine betaine, was first isolated from seed husk and the pulp of the fruit of C. Leonurus, and many other Asian plants and fruits. |
Stachydrine (hydrochloride) |
|
C3648-500 |
ApexBio |
500 mg |
EUR 328 |
|
Description: Stachydrine is an anti-metastatic agent.Stachydrine, a pyrrolidine betaine, was first isolated from seed husk and the pulp of the fruit of C. Leonurus, and many other Asian plants and fruits. |
) Barnidipine (hydrochloride) |
|
C3727-100 |
ApexBio |
100 mg |
EUR 203 |
|
Description: Barnidipine is a calcium-channel blocker.A calcium channel, an ion channel which displays selective permeability to calcium ions, is sometimes synonymous as voltage-dependent calcium channel, although there are also ligand-gated calcium channels. |
Barnidipine (hydrochloride) |
|
C3727-50 |
ApexBio |
50 mg |
EUR 155 |
|
Description: Barnidipine is a calcium-channel blocker.A calcium channel, an ion channel which displays selective permeability to calcium ions, is sometimes synonymous as voltage-dependent calcium channel, although there are also ligand-gated calcium channels. |
) MS049 (hydrochloride) |
|
C3776-10 |
ApexBio |
10 mg |
EUR 200 |
|
Description: IC50: 34 nM for PRMT4; 43 nM for PRMT6 MS049 is a dual PRMT4 and PRMT6 inhibitor. |
MS049 (hydrochloride) |
|
C3776-100 |
ApexBio |
100 mg |
EUR 1181 |
|
Description: IC50: 34 nM for PRMT4; 43 nM for PRMT6 MS049 is a dual PRMT4 and PRMT6 inhibitor. |
MS049 (hydrochloride) |
|
C3776-25 |
ApexBio |
25 mg |
EUR 382 |
|
Description: IC50: 34 nM for PRMT4; 43 nM for PRMT6 MS049 is a dual PRMT4 and PRMT6 inhibitor. |
MS049 (hydrochloride) |
|
C3776-5 |
ApexBio |
5 mg |
EUR 139 |
|
Description: IC50: 34 nM for PRMT4; 43 nM for PRMT6 MS049 is a dual PRMT4 and PRMT6 inhibitor. |
MS049 (hydrochloride) |
|
C3776-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 150 |
|
Description: IC50: 34 nM for PRMT4; 43 nM for PRMT6 MS049 is a dual PRMT4 and PRMT6 inhibitor. |
MS049 (hydrochloride) |
|
C3776-50 |
ApexBio |
50 mg |
EUR 653 |
|
Description: IC50: 34 nM for PRMT4; 43 nM for PRMT6 MS049 is a dual PRMT4 and PRMT6 inhibitor. |
) Guanabenz (hydrochloride) |
|
C3786-100 |
ApexBio |
100 mg |
EUR 231 |
|
Description: Guanabenz is an orally active ?2-adrenoceptor agonist with hypotensive effects [1]. The ?2 adrenergic receptors belong to a family of G protein-coupled receptor (GPCR), mediate many physiological actions of the endogenous catecholamines adrenaline and noradrenaline. |
Guanabenz (hydrochloride) |
|
C3786-50 |
ApexBio |
50 mg |
EUR 144 |
|
Description: Guanabenz is an orally active ?2-adrenoceptor agonist with hypotensive effects [1]. The ?2 adrenergic receptors belong to a family of G protein-coupled receptor (GPCR), mediate many physiological actions of the endogenous catecholamines adrenaline and noradrenaline. |
) Ulixertinib (hydrochloride) |
|
C3921-10 |
ApexBio |
10 mg |
EUR 406 |
|
Description: Ulixertinib, also named as BVD-523, is a novel and reversible inhibitor of ERK1/2. Ulixertinib potently and selectively inhibits the activity of ERK1 and ERK2 kinases in a reversible, ATP-competitive fashion [1]. |
Ulixertinib (hydrochloride) |
|
C3921-25 |
ApexBio |
25 mg |
EUR 661 |
|
Description: Ulixertinib, also named as BVD-523, is a novel and reversible inhibitor of ERK1/2. Ulixertinib potently and selectively inhibits the activity of ERK1 and ERK2 kinases in a reversible, ATP-competitive fashion [1]. |
Ulixertinib (hydrochloride) |
|
C3921-5 |
ApexBio |
5 mg |
EUR 250 |
|
Description: Ulixertinib, also named as BVD-523, is a novel and reversible inhibitor of ERK1/2. Ulixertinib potently and selectively inhibits the activity of ERK1 and ERK2 kinases in a reversible, ATP-competitive fashion [1]. |
) Chlorcyclizine (hydrochloride) |
|
C3989-100 |
ApexBio |
100 mg |
EUR 118 |
|
Description: Chlorcyclizine is a phenylpiperazine antagonist for histamine H1 receptor [1]. The histamine has been involved in modulating many physiological functions of the hypothalamus, such as arousal state, feeding, locomotor activity, and drinking. |
Chlorcyclizine (hydrochloride) |
|
C3989-1000 |
ApexBio |
1 g |
EUR 595 |
|
Description: Chlorcyclizine is a phenylpiperazine antagonist for histamine H1 receptor [1]. The histamine has been involved in modulating many physiological functions of the hypothalamus, such as arousal state, feeding, locomotor activity, and drinking. |
Chlorcyclizine (hydrochloride) |
|
C3989-250 |
ApexBio |
250 mg |
EUR 210 |
|
Description: Chlorcyclizine is a phenylpiperazine antagonist for histamine H1 receptor [1]. The histamine has been involved in modulating many physiological functions of the hypothalamus, such as arousal state, feeding, locomotor activity, and drinking. |
Chlorcyclizine (hydrochloride) |
|
C3989-500 |
ApexBio |
500 mg |
EUR 357 |
|
Description: Chlorcyclizine is a phenylpiperazine antagonist for histamine H1 receptor [1]. The histamine has been involved in modulating many physiological functions of the hypothalamus, such as arousal state, feeding, locomotor activity, and drinking. |
) Lofexidine (hydrochloride) |
|
C3990-1000 |
ApexBio |
1 g |
EUR 126 |
|
Description: Lofexidine is a ?2-Receptor agonist for opioid detoxification. Lofexidine shows a strong affinity for the ?2A-receptor subtype [1]. |
Lofexidine (hydrochloride) |
|
C3990-5.1 |
ApexBio |
10 mM (in 1mL H2O) |
EUR 113 |
|
Description: Lofexidine is a ?2-Receptor agonist for opioid detoxification. Lofexidine shows a strong affinity for the ?2A-receptor subtype [1]. |
Lofexidine (hydrochloride) |
|
C3990-500 |
ApexBio |
500 mg |
EUR 100 |
|
Description: Lofexidine is a ?2-Receptor agonist for opioid detoxification. Lofexidine shows a strong affinity for the ?2A-receptor subtype [1]. |
) Nortriptyline (hydrochloride) |
|
C4077-100 |
ApexBio |
100 mg |
EUR 163 |
|
Description: Ki: 3.4 nM: blocks the norepinephrine transporter.Ki: 161 nM: inhibits the serotonin transporter. |
Nortriptyline (hydrochloride) |
|
C4077-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 113 |
|
Description: Ki: 3.4 nM: blocks the norepinephrine transporter.Ki: 161 nM: inhibits the serotonin transporter. |
Nortriptyline (hydrochloride) |
|
C4077-50 |
ApexBio |
50 mg |
EUR 116 |
|
Description: Ki: 3.4 nM: blocks the norepinephrine transporter.Ki: 161 nM: inhibits the serotonin transporter. |
) Imipramine (hydrochloride) |
|
C4117-5.1 |
ApexBio |
10 mM (in 1mL H2O) |
EUR 113 |
|
Description: Imipramine (hydrochloride) is a tricyclic antidepressant and is mainly used in the treatment of major depression and enuresis [1]. Antidepressants are antagonists of many neurotransmitter receptors in human brain [3]. |
Imipramine (hydrochloride) |
|
C4117-5000 |
ApexBio |
5 g |
EUR 108 |
|
Description: Imipramine (hydrochloride) is a tricyclic antidepressant and is mainly used in the treatment of major depression and enuresis [1]. Antidepressants are antagonists of many neurotransmitter receptors in human brain [3]. |
) Clorgyline (hydrochloride) |
|
C4137-100 |
ApexBio |
100 mg |
EUR 224 |
|
Description: Clorgyline (hydrochloride) is an irreversible, potent and selective monoamine oxidase (MAO) A inhibitor with Ki values of 0.054 and 58 ?M and IC50 values of 0.0012 and 1.9 ?M for MAO-A and MAO-B, respectively [1][2]. |
Clorgyline (hydrochloride) |
|
C4137-25 |
ApexBio |
25 mg |
EUR 110 |
|
Description: Clorgyline (hydrochloride) is an irreversible, potent and selective monoamine oxidase (MAO) A inhibitor with Ki values of 0.054 and 58 ?M and IC50 values of 0.0012 and 1.9 ?M for MAO-A and MAO-B, respectively [1][2]. |
Clorgyline (hydrochloride) |
|
C4137-50 |
ApexBio |
50 mg |
EUR 154 |
|
Description: Clorgyline (hydrochloride) is an irreversible, potent and selective monoamine oxidase (MAO) A inhibitor with Ki values of 0.054 and 58 ?M and IC50 values of 0.0012 and 1.9 ?M for MAO-A and MAO-B, respectively [1][2]. |
) Doxepin (hydrochloride) |
|
C4153-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 113 |
|
Description: Doxepin, a tricyclic antidepressant, is a potent histamine H1 antagonist [1]. The histamine receptors belong to a family of G protein?coupled receptors activated by their primary endogenous ligand histamine. |
Doxepin (hydrochloride) |
|
C4153-5000 |
ApexBio |
5 g |
EUR 168 |
|
Description: Doxepin, a tricyclic antidepressant, is a potent histamine H1 antagonist [1]. The histamine receptors belong to a family of G protein?coupled receptors activated by their primary endogenous ligand histamine. |
) Anhydrochlortetracycline (hydrochloride) |
|
C4218-1 |
ApexBio |
1 mg |
EUR 132 |
|
Description: Anhydrochlortetracycline was produced by the acid degradation of chlortetracycline. Anhydrochlortetracycline only have a fraction of the antibacterial activity of chlortetracycline. Anhydrochlortetracycline strongly inhibited the growth of Streptomyces aureofaciem. |
Anhydrochlortetracycline (hydrochloride) |
|
C4218-5 |
ApexBio |
5 mg |
EUR 255 |
|
Description: Anhydrochlortetracycline was produced by the acid degradation of chlortetracycline. Anhydrochlortetracycline only have a fraction of the antibacterial activity of chlortetracycline. Anhydrochlortetracycline strongly inhibited the growth of Streptomyces aureofaciem. |
) Anhydrotetracycline (hydrochloride) |
|
C4291-100 |
ApexBio |
100 mg |
EUR 241 |
|
Description: Anhydrotetracycline (hydrochloride) (ATC) is a powerful effector for the tetracycline repressor (TetR) and reverse tetracycline repressor (revTetR) systems [1]. |
Anhydrotetracycline (hydrochloride) |
|
C4291-25 |
ApexBio |
25 mg |
EUR 123 |
|
Description: Anhydrotetracycline (hydrochloride) (ATC) is a powerful effector for the tetracycline repressor (TetR) and reverse tetracycline repressor (revTetR) systems [1]. |
Lenalidomide hydrochloride
)
